caffeic acid |
3,4-Dihydroxycinnamic acid |
331-39-5 |
trans-caffeic acid |
501-16-6 |
3-(3,4-dihydroxyphenyl)acrylic acid |
3,4-Dihydroxybenzeneacrylic acid |
(E)-3-(3,4-dihydroxyphenyl)acrylic acid |
(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid |
3-(3,4-Dihydroxyphenyl)-2-propenoic acid |
(E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid |
Caffeicacid |
Cinnamic acid, 3,4-dihydroxy- |
2-Propenoic acid, 3-(3,4-dihydroxyphenyl)- |
4-(2-Carboxyethenyl)-1,2-dihydroxybenzene |
trans-Caffeate |
CCRIS 847 |
NSC 57197 |
3,4-Dihydroxy-trans-cinnamate |
3-(3,4-Dihydroxyphenyl)propenoic acid |
(E)-3,4-dihydroxycinnamic acid |
HSDB 7088 |
UNII-U2S3A33KVM |
4-(2'-Carboxyvinyl)-1,2-dihydroxybenzene |
2-Propenoic acid, 3-(3,4-dihydroxyphenyl)-, (E)- |
71693-97-5 |
EINECS 206-361-2 |
U2S3A33KVM |
NSC-57197 |
Caffeate |
NSC-623438 |
CHEBI:16433 |
AI3-63211 |
trans-3,4-Dihydroxycinnamic Acid |
3-(3,4-Dihydroxy phenyl)-2-propenoic acid |
NSC57197 |
331-89-5 |
CHEMBL145 |
3-(3,4-dihydroxyphenyl)prop-2-enoic acid |
MLS000069738 |
CHEBI:36281 |
MFCD00004392 |
NSC623438 |
2-Propenoic acid, 3-(3,4-dihydroxyphenyl)-, (2E)- |
SMR000058214 |
(2E)-3-(3,4-dihydroxyphenyl)acrylic acid |
CAFFEIC ACID (IARC) |
CAFFEIC ACID [IARC] |
Caffeic acid - Natural |
SR-01000000203 |
caffeic acid, (E)-isomer |
DTXSID5020231 |
caffeic-acid |
Caffeic acid pure |
Caffeic acid, 1 |
Caffeic acid 1000 microg/mL in Acetone |
3,4-dihydroxycinnamic acid (caffeic acid) |
Caffeic Acid,(S) |
Caffeic Acid1507 |
Caffeic acid, trans- |
3,4-dihydroxycinnamate |
CAFFEIC ACID natural |
Opera_ID_1700 |
CAFFEIC ACID [MI] |
CAFFEIC ACID [DSC] |
Cinnamic acid,4-dihydroxy- |
3,4-Dihydroxycinnamic acid, predominantly trans |
CAFFEIC ACID [HSDB] |
CAFFEIC ACID [INCI] |
3,4-Dihydroxybenzeneacrylate |
SCHEMBL23358 |
MLS001076493 |
MLS002207132 |
MLS002222302 |
MLS006011849 |
BIDD:ER0456 |
DTXCID10231 |
SPECTRUM1503987 |
CAFFEIC ACID [WHO-DD] |
2-Propenoic acid,3-(3,4-dihydroxyphenyl)-, (2E)- |
3,4-Dihydroxycinnamate, XVII |
BDBM4375 |
cid_689043 |
GTPL5155 |
AMY3943 |
Trans 3,4-Dihydroxycinnamic acid |
DTXSID901316055 |
HMS2235G09 |
HMS3260J17 |
HMS3649O17 |
BCP28271 |
HY-N0172 |
Tox21_200648 |
Tox21_500208 |
BBL012113 |
Caffeic Acid - CAS 331-39-5 |
CCG-38895 |
s2277 |
STK397812 |
Caffeic acid, >=98.0% (HPLC) |
2-Propenoic acid,4-dihydroxyphenyl)- |
AKOS000144463 |
AC-8006 |
CS-8205 |
DB01880 |
LP00208 |
SDCCGMLS-0002982.P003 |
SDCCGSBI-0050196.P004 |
NCGC00017364-04 |
NCGC00017364-05 |
NCGC00017364-06 |
NCGC00017364-07 |
NCGC00017364-08 |
NCGC00017364-09 |
NCGC00017364-10 |
NCGC00017364-11 |
NCGC00017364-12 |
NCGC00017364-13 |
NCGC00017364-22 |
NCGC00022654-03 |
NCGC00022654-04 |
NCGC00022654-05 |
NCGC00022654-06 |
NCGC00022654-07 |
NCGC00022654-08 |
NCGC00022654-09 |
NCGC00258202-01 |
NCGC00260893-01 |
NCGC00263641-01 |
(E)-3-(3,4-dihydroxyphenyl)acrylicacid |
AS-10895 |
BP-30112 |
CAS-331-39-5 |
SMR004703501 |
XC164210 |
4-(2'Carboxyvinyl)-1,2-dihydroxybenzene |
Caffeic acid, purum, >=95.0% (HPLC) |
DB-318886 |
DB-321780 |
HY-121231 |
AB00490047 |
CS-0081280 |
EU-0100208 |
NS00010313 |
SW197202-3 |
2-Morpholin-4-yl-isonicotinicacidhydrochloride |
2-Propenoic acid, 3-(3,4-dihdroxyphenyl)- |
(E)-3-(3,4-dihydroxyphenyl)prop-2-enoicacid |
C 0625 |
C-1500 |
C01197 |
C01481 |
EN300-1067793 |
(2E)-3-(3,4-Dihydroxyphenyl)-2-propenoic acid |
A851723 |
CAFFEIC ACID (CONSTITUENT OF BLACK COHOSH) |
Q414116 |
SR-01000000203-2 |
SR-01000000203-6 |
SR-01000000203-7 |
SR-01000000203-8 |
BRD-K09900591-001-06-9 |
SR-01000000203-13 |
CAFFEIC ACID (CONSTITUENT OF BLACK COHOSH) [DSC] |
F3096-1708 |
Z240113804 |
2',3-DIHYDROXY-4,4',6'-TRIMETHOXYCHALCONE_met021 |
2',4-DIHYDROXY-3,4',6'-TRIMETHOXYCHALCONE_met023 |
8B3E4DA7-F3B0-4972-A315-2E387071737F |
trans-Caffeic acid, certified reference material, TraceCERT(R) |
Caffeic acid, matrix substance for MALDI-MS, >=99.0% (HPLC) |
Caffeic acid, United States Pharmacopeia (USP) Reference Standard |
Caffeic acid, matrix substance for MALDI-MS, >=99.0% (HPLC), powder, light beige |
InChI=1/C9H8O4/c10-7-3-1-6(5-8(7)11)2-4-9(12)13/h1-5,10-11H,(H,12,13)/b4-2 |